RD
Retinal Degeneration Fund
Retinal Degeneration Fund is a seed to Series B stage investment firm. It has made 5 investments. 40% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (40% of deals). Average disclosed round size is $72.0M (across 4 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Perceive Bio | Series A | $15M | Feb 2025 |
 SparingVision | Series B | — | Sep 2022 |
| SStargazer Pharmaceuticals | Series A | $57M | Nov 2020 |
| OOsanni Bio | Series B | $190M | — |
 Amber | Seed | $26M | — |
Top Co-Investors
RD Fund2 shared
Catalio Capital Management1 shared
GV1 shared
Braidwell LP1 shared
Deerfield1 shared
Playground Global1 shared
India Quotient1 shared
Pillar VC1 shared
Eli Lilly1 shared
Hummingbird Ventures1 shared
venBio1 shared
Pontifax1 shared
Canaan Partners1 shared
Novo Capital1 shared
Bpifrance1 shared
4BIO Capital1 shared
Ysios Capital1 shared
Jeito Capital1 shared
BPI1 shared
Last updated: 27 September 2026